메뉴 건너뛰기




Volumn 31, Issue 3, 2011, Pages 260-267

Management of HCV infection in chronic kidney disease;Manejo de la infección por el VHC en la enfermedad renal crónica

Author keywords

Chronic kidney disease; Hemodialysis; Hepatitis C virus; Interferon; Liver biopsy; Renal transplantation; Ribavirin

Indexed keywords

ARTICLE; BIOPSY; CHRONIC KIDNEY FAILURE; HEPATITIS C; HUMAN; PATHOLOGY;

EID: 79958275028     PISSN: 02116995     EISSN: None     Source Type: Journal    
DOI: 10.3265/Nefrologia.pre2011.Jan.10768     Document Type: Article
Times cited : (17)

References (115)
  • 1
    • 14844335024 scopus 로고    scopus 로고
    • National surveillance of dialysis associated diseases in the United States 2002
    • Finelli L, Miller JT, Tokars JI, Alter MJ, Arduino MJ. National surveillance of dialysis associated diseases in the United States, 2002. Semin Dial 2005;18(1):52-61.
    • (2005) Semin Dial , vol.18 , Issue.1 , pp. 52-61
    • Finelli, L.1    Miller, J.T.2    Tokars, J.I.3    Alter, M.J.4    Arduino, M.J.5
  • 2
    • 12144288521 scopus 로고    scopus 로고
    • Marked reduction in the prevalence of hepatitis C virus infection in hemodialysis patients: causes and consequences
    • Espinosa M, Martín-Malo A, Ojeda R, Santamara R, Soriano S, Aguera M, et al. Marked reduction in the prevalence of hepatitis C virus infection in hemodialysis patients: causes and consequences. Am J Kidney Dis 2004;43(4):685-9.
    • (2004) Am J Kidney Dis , vol.43 , Issue.4 , pp. 685-689
    • Espinosa, M.1    Martín-Malo, A.2    Ojeda, R.3    Santamara, R.4    Soriano, S.5    Aguera, M.6
  • 3
    • 11144358579 scopus 로고    scopus 로고
    • The changing epidemiology of hepatitis C virus (HCV) infection in haemodialysis: European multicentre study
    • Jadoul M, Poignet JL, Geddes C, Locatelli F, Medin C, Krajewska M, et al. The changing epidemiology of hepatitis C virus (HCV) infection in haemodialysis: European multicentre study. Nephrol Dial Transplant 2004;19(4):904-9.
    • (2004) Nephrol Dial Transplant , vol.19 , Issue.4 , pp. 904-909
    • Jadoul, M.1    Poignet, J.L.2    Geddes, C.3    Locatelli, F.4    Medin, C.5    Krajewska, M.6
  • 4
    • 2442642562 scopus 로고    scopus 로고
    • Patterns of hepatitis C prevalence and seroconversion in hemodialysis units from three continents: the DOPPS
    • Fissell RB, Bragg-Gresaham JL, Woods JD, Jadoul M, Gillespie B, Hedderwick SA, et al. Patterns of hepatitis C prevalence and seroconversion in hemodialysis units from three continents: the DOPPS. Kidney Int 2004;65(6):2335-42.
    • (2004) Kidney Int , vol.65 , Issue.6 , pp. 2335-2342
    • Fissell, R.B.1    Bragg-Gresaham, J.L.2    Woods, J.D.3    Jadoul, M.4    Gillespie, B.5    Hedderwick, S.A.6
  • 5
  • 6
    • 0036719231 scopus 로고    scopus 로고
    • PHV Study Group Prevalence and risk factors of hepatitis C virus infection in haemodialysis patients: a multicentre study in 2796 patients
    • Hinrichsen H, Leimenstoll G, Stegen G, Schrader H, Fölsch UR, Schmidt WE; PHV Study Group. Prevalence and risk factors of hepatitis C virus infection in haemodialysis patients: a multicentre study in 2796 patients. Gut 2002;51(3):429-33.
    • (2002) Gut , vol.51 , Issue.3 , pp. 429-433
    • Hinrichsen, H.1    Leimenstoll, G.2    Stegen, G.3    Schrader, H.4    Fölsch, U.R.5    Schmidt, W.E.6
  • 7
    • 85047695050 scopus 로고
    • High prevalence of and risk factors for hepatitis C in haemodialysis patients in Saudi Arabia: a need for new dialysis strategies
    • Huraib S, Al-Rashed R, Aldrees A, Aljefry M, Arif M, Al-Faleh FA. High prevalence of and risk factors for hepatitis C in haemodialysis patients in Saudi Arabia: a need for new dialysis strategies. Nephrol Dial Transplant 1995;10(4):470-4.
    • (1995) Nephrol Dial Transplant , vol.10 , Issue.4 , pp. 470-474
    • Huraib, S.1    Al-Rashed, R.2    Aldrees, A.3    Aljefry, M.4    Arif, M.5    Al-Faleh, F.A.6
  • 8
    • 33947227223 scopus 로고    scopus 로고
    • Infection by the hepatitis C virus in chronic renal failure patients undergoing hemodialysis in Mato Grosso state, central Brazil: a cohort study
    • Santos MA, Souto FJ. Infection by the hepatitis C virus in chronic renal failure patients undergoing hemodialysis in Mato Grosso state, central Brazil: a cohort study. BMC Public Health 2007;7:32.
    • (2007) BMC Public Health , vol.7 , pp. 32
    • Santos, M.A.1    Souto, F.J.2
  • 9
    • 0034910145 scopus 로고    scopus 로고
    • Hepatitis HIV infection during haemodialysis
    • Saha D, Agarwal SK. Hepatitis and HIV infection during haemodialysis. J Indian Med Assoc 2001;99(4):194-9.
    • (2001) J Indian Med Assoc , vol.99 , Issue.4 , pp. 194-199
    • Saha, D.1    Agarwal, S.K.2
  • 10
    • 9144245801 scopus 로고    scopus 로고
    • The role of hemodialysis machines dedication in reducing Hepatitis C transmission in the dialysis setting in Iran: a multicenter prospective interventional study
    • Shamshirsaz AA, Kamgar M, Bekheirnia MR, Ayazi F, Hashemi SR, Bouzari N, et al. The role of hemodialysis machines dedication in reducing Hepatitis C transmission in the dialysis setting in Iran: a multicenter prospective interventional study. BMC Nephrol 2004;5(1):13.
    • (2004) BMC Nephrol , vol.5 , Issue.1 , pp. 13
    • Shamshirsaz, A.A.1    Kamgar, M.2    Bekheirnia, M.R.3    Ayazi, F.4    Hashemi, S.R.5    Bouzari, N.6
  • 11
    • 0026910821 scopus 로고
    • Prevalence of antibodies to hepatitis C virus in patients receiving renal replacement therapy, and in the staff caring for them
    • Blackmore TK, Stace NH, Maddocks P, Hatfield P. Prevalence of antibodies to hepatitis C virus in patients receiving renal replacement therapy, and in the staff caring for them. Aust N Z J Med 1992;22(4):353-7.
    • (1992) Aust N Z J Med , vol.22 , Issue.4 , pp. 353-357
    • Blackmore, T.K.1    Stace, N.H.2    Maddocks, P.3    Hatfield, P.4
  • 12
    • 0033783124 scopus 로고    scopus 로고
    • The prevalence and incidence of hepatitis C virus infections among dialysis patients in the Netherlands: a nationwide prospective study
    • Schneeberger PM, Keur I, Van Loon AM, Mortier D, De Coul KO, Van Haperen AV, et al. The prevalence and incidence of hepatitis C virus infections among dialysis patients in the Netherlands: a nationwide prospective study. J Infect Dis 2000;182(5):1291-9.
    • (2000) J Infect Dis , vol.182 , Issue.5 , pp. 1291-1299
    • Schneeberger, P.M.1    Keur, I.2    Van Loon, A.M.3    Mortier, D.4    De Coul, K.O.5    Van Haperen, A.V.6
  • 13
    • 85047698711 scopus 로고
    • High prevalence of antibodies to hepatitis C virus in three haemodialysis centres in south-western Poland
    • Hruby Z, Sliwinski J, Molin I, Zalewska M, Knysz B, Czyz W, et al. High prevalence of antibodies to hepatitis C virus in three haemodialysis centres in south-western Poland. Nephrol Dial Transplant 1993;8(8):740-3.
    • (1993) Nephrol Dial Transplant , vol.8 , Issue.8 , pp. 740-743
    • Hruby, Z.1    Sliwinski, J.2    Molin, I.3    Zalewska, M.4    Knysz, B.5    Czyz, W.6
  • 14
    • 0028883546 scopus 로고
    • The prevalence of antibodies to hepatitis C virus at two haemodialysis units in South Africa
    • Cassidy MJ, Jankelson D, Becker M, Dunne T, Walzl G, Moosa MR. The prevalence of antibodies to hepatitis C virus at two haemodialysis units in South Africa. S Afr Med J 1995;85(10):996-8.
    • (1995) S Afr Med J , vol.85 , Issue.10 , pp. 996-998
    • Cassidy, M.J.1    Jankelson, D.2    Becker, M.3    Dunne, T.4    Walzl, G.5    Moosa, M.R.6
  • 15
    • 0028125056 scopus 로고
    • Hepatitis C virus infection in patients with chronic liver disease or chronic renal failure and blood donors in Thailand
    • Luengrojanakul P, Vareesangthip K, Chainuvati T, Murata K, Tsuda F, Tokita H, et al. Hepatitis C virus infection in patients with chronic liver disease or chronic renal failure and blood donors in Thailand. J Med Virol 1994;44(3):287-92.
    • (1994) J Med Virol , vol.44 , Issue.3 , pp. 287-292
    • Luengrojanakul, P.1    Vareesangthip, K.2    Chainuvati, T.3    Murata, K.4    Tsuda, F.5    Tokita, H.6
  • 16
    • 31144469185 scopus 로고    scopus 로고
    • Hepatitis C virus infection among dialysis patients in Tunisia: incidence and molecular evidence for nosocomial transmission
    • Hmaied F, Ben Mamou M, Saune-Sandres K, Rostaing L, Slim A, Arrouji Z, et al. Hepatitis C virus infection among dialysis patients in Tunisia: incidence and molecular evidence for nosocomial transmission. J Med Virol 2006;78(2):185-91.
    • (2006) J Med Virol , vol.78 , Issue.2 , pp. 185-191
    • Hmaied, F.1    Ben Mamou, M.2    Saune-Sandres, K.3    Rostaing, L.4    Slim, A.5    Arrouji, Z.6
  • 17
    • 0032065536 scopus 로고    scopus 로고
    • Effects of hepatitis C infection and renal transplantation on survival in end-stage renal disease The New England Organ Bank Hepatitis C Study Group
    • Pereira BJ, Natov SN, Bouthot BA, Murthy BV, Ruthazer R, Schmid CH, et al. Effects of hepatitis C infection and renal transplantation on survival in end-stage renal disease. The New England Organ Bank Hepatitis C Study Group. Kidney Int 1998;53(5):1374-81.
    • (1998) Kidney Int , vol.53 , Issue.5 , pp. 1374-1381
    • Pereira, B.J.1    Natov, S.N.2    Bouthot, B.A.3    Murthy, B.V.4    Ruthazer, R.5    Schmid, C.H.6
  • 18
    • 0032572688 scopus 로고    scopus 로고
    • Retrospective study on the impact of hepatitis C virus infection on kidney transplant patients over 20 years
    • Hanafusa T, Ichikawa Y, Kishikawa H, Kyo M, Fukunishi T, Kokado Y, et al. Retrospective study on the impact of hepatitis C virus infection on kidney transplant patients over 20 years. Transplantation 1998;66(4):471-6.
    • (1998) Transplantation , vol.66 , Issue.4 , pp. 471-476
    • Hanafusa, T.1    Ichikawa, Y.2    Kishikawa, H.3    Kyo, M.4    Fukunishi, T.5    Kokado, Y.6
  • 19
    • 0030825030 scopus 로고    scopus 로고
    • Hepatitis C in renal transplantation
    • Vosnides GG. Hepatitis C in renal transplantation. Kidney Int 1997;52(3):843-61.
    • (1997) Kidney Int , vol.52 , Issue.3 , pp. 843-861
    • Vosnides, G.G.1
  • 20
    • 0034651580 scopus 로고    scopus 로고
    • Pathogenesis, natural history, treatment and prevention of hepatitis C
    • Liang TJ, Rehermann B, Seeff LB, Hoofnagle JH. Pathogenesis, natural history, treatment and prevention of hepatitis C. Ann Intern Med 2000;132(4):296-305.
    • (2000) Ann Intern Med , vol.132 , Issue.4 , pp. 296-305
    • Liang, T.J.1    Rehermann, B.2    Seeff, L.B.3    Hoofnagle, J.H.4
  • 21
    • 22044433989 scopus 로고    scopus 로고
    • Natural history of hepatitis C
    • Thomas DL, Seeff LB. Natural history of hepatitis C. Clin Liver Dis 2005;9(3):383-98.
    • (2005) Clin Liver Dis , vol.9 , Issue.3 , pp. 383-398
    • Thomas, D.L.1    Seeff, L.B.2
  • 22
    • 0029894579 scopus 로고    scopus 로고
    • The natural history of chronic hepatitis C infection
    • Strader DB, Seeff LB. The natural history of chronic hepatitis C infection. Eur J Gastroenterol Hepatol 1996;8(4):324-8.
    • (1996) Eur J Gastroenterol Hepatol , vol.8 , Issue.4 , pp. 324-328
    • Strader, D.B.1    Seeff, L.B.2
  • 23
    • 0036828840 scopus 로고    scopus 로고
    • National Institutes of Health Consensus Development Conference: management of hepatitis C: 2002
    • Seeff LB, Hoofnagle JH. National Institutes of Health Consensus Development Conference: management of hepatitis C: 2002. Hepatology 2002;36(5 Suppl 1):S1-2.
    • (2002) Hepatology , vol.36 , Issue.5 SUPPL. 1
    • Seeff, L.B.1    Hoofnagle, J.H.2
  • 24
    • 0036829816 scopus 로고    scopus 로고
    • Natural history of chronic hepatitis C
    • Seeff LB. Natural history of chronic hepatitis C. Hepatology 2002;36(5 Suppl 1):S35-S46.
    • (2002) Hepatology , vol.36 , Issue.5 SUPPL. 1
    • Seeff, L.B.1
  • 26
    • 7044272630 scopus 로고    scopus 로고
    • Hepatocellular carcinoma in cirrhosis: Incidente and risk factors
    • Fattovich G, Stroffolini T, Zagni I, Donato F. Hepatocellular carcinoma in cirrhosis: Incidente and risk factors. Gastroenterology 2004;127(5 Suppl 1):S35-50.
    • (2004) Gastroenterology , vol.127 , Issue.5 SUPPL. 1
    • Fattovich, G.1    Stroffolini, T.2    Zagni, I.3    Donato, F.4
  • 27
    • 33947360829 scopus 로고    scopus 로고
    • Sustained virological response to interferon-alpha is associated with improved outcome in HCV-related cirrhosis: A retrospective study
    • Bruno S, Stroffolini T, Colombo M, Bollani S, Benvegnu L, Mazzella G, et al. Sustained virological response to interferon-alpha is associated with improved outcome in HCV-related cirrhosis: A retrospective study. Hepatology 2007;45(3):579-87.
    • (2007) Hepatology , vol.45 , Issue.3 , pp. 579-587
    • Bruno, S.1    Stroffolini, T.2    Colombo, M.3    Bollani, S.4    Benvegnu, L.5    Mazzella, G.6
  • 29
    • 0030933395 scopus 로고    scopus 로고
    • Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups
    • Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet 1997;349(9055):825-32.
    • (1997) Lancet , vol.349 , Issue.9055 , pp. 825-832
    • Poynard, T.1    Bedossa, P.2    Opolon, P.3
  • 30
    • 0035895302 scopus 로고    scopus 로고
    • The relationship of acute transfusion-associated hepatitis to the development of cirrhosis in the presence of alcohol abuse
    • Harris DR, Gonin R, Alter HJ, Wright EC, Buskell ZJ, Hollinger FB, et al. The relationship of acute transfusion-associated hepatitis to the development of cirrhosis in the presence of alcohol abuse. Ann Intern Med 2001;134(2):120-4.
    • (2001) Ann Intern Med , vol.134 , Issue.2 , pp. 120-124
    • Harris, D.R.1    Gonin, R.2    Alter, H.J.3    Wright, E.C.4    Buskell, Z.J.5    Hollinger, F.B.6
  • 31
    • 21344446513 scopus 로고    scopus 로고
    • Steatosis: co-factor in other liver diseases
    • Powell EE, Jonsson JR, Clouston AD. Steatosis: co-factor in other liver diseases. Hepatology 2005;42(1):5-13.
    • (2005) Hepatology , vol.42 , Issue.1 , pp. 5-13
    • Powell, E.E.1    Jonsson, J.R.2    Clouston, A.D.3
  • 32
    • 0029767871 scopus 로고    scopus 로고
    • ESRD patient mortality with adjustment for comorbid conditions in Lombardy (Italy) versus the United States
    • Marcelli D, Stannard D, Conte F, Held PJ, Locatelli F, Port FK. ESRD patient mortality with adjustment for comorbid conditions in Lombardy (Italy) versus the United States. Kidney Int 1996;50(3):1013-8.
    • (1996) Kidney Int , vol.50 , Issue.3 , pp. 1013-1018
    • Marcelli, D.1    Stannard, D.2    Conte, F.3    Held, P.J.4    Locatelli, F.5    Port, F.K.6
  • 33
    • 0033542845 scopus 로고    scopus 로고
    • Cancer in patients on dialysis for end-stage renal disease: an international collaborative study
    • Maisonneuve P, Agodoa L, Gellert R, Stewart JH, Buccianti G, Lowenfels AB, et al. Cancer in patients on dialysis for end-stage renal disease: an international collaborative study. Lancet 1999;354(9173):93-9.
    • (1999) Lancet , vol.354 , Issue.9173 , pp. 93-99
    • Maisonneuve, P.1    Agodoa, L.2    Gellert, R.3    Stewart, J.H.4    Buccianti, G.5    Lowenfels, A.B.6
  • 34
    • 0033770522 scopus 로고    scopus 로고
    • Prognosis of anti-hepatitis C virus antibody-positive patients on regular hemodialysis therapy
    • Nakayama E, Akiba T, Marumo F, Sato C. Prognosis of anti-hepatitis C virus antibody-positive patients on regular hemodialysis therapy. J Am Soc Nephrol 2000;11(10):1896-902.
    • (2000) J Am Soc Nephrol , vol.11 , Issue.10 , pp. 1896-1902
    • Nakayama, E.1    Akiba, T.2    Marumo, F.3    Sato, C.4
  • 35
    • 14644390213 scopus 로고    scopus 로고
    • The liver biopsy in chronic hepatitis C: a view from the other side of the microscope
    • Kleiner DE. The liver biopsy in chronic hepatitis C: a view from the other side of the microscope. Semin Liver Dis 2005;25(1):52-64.
    • (2005) Semin Liver Dis , vol.25 , Issue.1 , pp. 52-64
    • Kleiner, D.E.1
  • 36
    • 10744224920 scopus 로고    scopus 로고
    • Steatosis affects chronic hepatitis C progression in a genotype specific way
    • Rubbia-Brandt L, Fabris P, Paganin S, Leandro G, Male PJ, Giostra E, et al. Steatosis affects chronic hepatitis C progression in a genotype specific way. Gut 2004;53(3):406-12.
    • (2004) Gut , vol.53 , Issue.3 , pp. 406-412
    • Rubbia-Brandt, L.1    Fabris, P.2    Paganin, S.3    Leandro, G.4    Male, P.J.5    Giostra, E.6
  • 37
    • 0038122773 scopus 로고    scopus 로고
    • Effect of treatment with peginterferon or interferon alfa-2b and ribavirin on steatosis in patients infected with hepatitis C
    • Poynard T, Ratziu V, McHutchison J, Manns M, Goodman Z, Zeuzem S, et al. Effect of treatment with peginterferon or interferon alfa-2b and ribavirin on steatosis in patients infected with hepatitis C. Hepatology 2003;38(1):75-85.
    • (2003) Hepatology , vol.38 , Issue.1 , pp. 75-85
    • Poynard, T.1    Ratziu, V.2    McHutchison, J.3    Manns, M.4    Goodman, Z.5    Zeuzem, S.6
  • 38
    • 0028915570 scopus 로고
    • Hepatic iron concentration as a predictor of response to interferon alfa therapy in chronic hepatitis C
    • Olynyk JK, Reddy KR, Di Bisceglie AM, Jeffers LJ, Parker TI, Radick JL, et al. Hepatic iron concentration as a predictor of response to interferon alfa therapy in chronic hepatitis C. Gastroenterology 1995;108(4):1104-9.
    • (1995) Gastroenterology , vol.108 , Issue.4 , pp. 1104-1109
    • Olynyk, J.K.1    Reddy, K.R.2    Di Bisceglie, A.M.3    Jeffers, L.J.4    Parker, T.I.5    Radick, J.L.6
  • 39
    • 74549158417 scopus 로고    scopus 로고
    • Kidney Disease Improving Global Outcomes. Clinical practice guidelines for the prevention, diagnosis, evaluation, and treatment of hepatitis C in chronic kidney disease
    • Kidney Disease Improving Global Outcomes. Clinical practice guidelines for the prevention, diagnosis, evaluation, and treatment of hepatitis C in chronic kidney disease. Kidney Int 2008;73(Suppl 109):S53-S68.
    • (2008) Kidney Int , vol.73 , Issue.SUPPL. 109
  • 40
    • 65449136656 scopus 로고    scopus 로고
    • American Association for the Study of Liver Diseases. Diagnosis, management, and treatment of hepatitis C: an update
    • Ghany MG, Strader DB, Thomas DL, Seeff LB. American Association for the Study of Liver Diseases. Diagnosis, management, and treatment of hepatitis C: an update. Hepatology 2009;49(4):1335-74.
    • (2009) Hepatology , vol.49 , Issue.4 , pp. 1335-1374
    • Ghany, M.G.1    Strader, D.B.2    Thomas, D.L.3    Seeff, L.B.4
  • 41
    • 0019813866 scopus 로고
    • Formulation and application of a numeral scoring system for assessing histological activity in asymptomatic chronic active hepatitis
    • Knodell RG, Ishak KG, Black WC, et al. Formulation and application of a numeral scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981;1(5):431-5.
    • (1981) Hepatology , vol.1 , Issue.5 , pp. 431-435
    • Knodell, R.G.1    Ishak, K.G.2    Black, W.C.3
  • 43
    • 0036792679 scopus 로고    scopus 로고
    • Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection
    • Regev A, Berho M, Jeffers LJ, Milikowski C, Molina EG, Pyrsopoulos NT, et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 2002;97(10):2614-8.
    • (2002) Am J Gastroenterol , vol.97 , Issue.10 , pp. 2614-2618
    • Regev, A.1    Berho, M.2    Jeffers, L.J.3    Milikowski, C.4    Molina, E.G.5    Pyrsopoulos, N.T.6
  • 45
    • 0027423952 scopus 로고
    • Liver disease patterns in hemodialysis patients with antibodies to hepatitis C virus
    • Caramelo C, Ortiz A, Aguilera B, Porres JC, Navas S, Marriott E, et al. Liver disease patterns in hemodialysis patients with antibodies to hepatitis C virus. Am J Kidney Dis 1993;22(6):822-8.
    • (1993) Am J Kidney Dis , vol.22 , Issue.6 , pp. 822-828
    • Caramelo, C.1    Ortiz, A.2    Aguilera, B.3    Porres, J.C.4    Navas, S.5    Marriott, E.6
  • 47
    • 0032919671 scopus 로고    scopus 로고
    • Comparison of clinical features and liver histology in hepatitis C-positive dialysis patients and renal transplant recipients
    • Glicklich D, Thung SN, Kapoian T, Tellis V, Reinus JF. Comparison of clinical features and liver histology in hepatitis C-positive dialysis patients and renal transplant recipients. Am J Gastroenterol 1999;94(1):159-63.
    • (1999) Am J Gastroenterol , vol.94 , Issue.1 , pp. 159-163
    • Glicklich, D.1    Thung, S.N.2    Kapoian, T.3    Tellis, V.4    Reinus, J.F.5
  • 48
    • 0027504601 scopus 로고
    • Hepatitis C virus RNA in anti-HCV positive hemodialyzed patients: significance and therapeutic implications
    • Pol S, Romeo R, Zins B, Driss F, Lebkiri B, Carnot F, et al. Hepatitis C virus RNA in anti-HCV positive hemodialyzed patients: significance and therapeutic implications. Kidney Int 1993;44(5):1097-100.
    • (1993) Kidney Int , vol.44 , Issue.5 , pp. 1097-1100
    • Pol, S.1    Romeo, R.2    Zins, B.3    Driss, F.4    Lebkiri, B.5    Carnot, F.6
  • 49
    • 0032787332 scopus 로고    scopus 로고
    • Chronic hepatitis C infection in patients with end stage renal disease: characterization of liver histology and viral load in patients awaiting renal transplantation
    • Sterling RK, Sanyal AJ, Luketic VA, Stravitz RT, King AL, Post AB, et al. Chronic hepatitis C infection in patients with end stage renal disease: characterization of liver histology and viral load in patients awaiting renal transplantation. Am J Gastroenterol 1999;94(12):3576-82.
    • (1999) Am J Gastroenterol , vol.94 , Issue.12 , pp. 3576-3582
    • Sterling, R.K.1    Sanyal, A.J.2    Luketic, V.A.3    Stravitz, R.T.4    King, A.L.5    Post, A.B.6
  • 50
    • 0032951872 scopus 로고    scopus 로고
    • Impact of hepatitis B and C virus on kidney transplantation outcome
    • Mathurin P, Mouquet C, Poynard T, Sylla C, Benalia H, Fretz C, et al. Impact of hepatitis B and C virus on kidney transplantation outcome. Hepatology 1999;29(1):257-63.
    • (1999) Hepatology , vol.29 , Issue.1 , pp. 257-263
    • Mathurin, P.1    Mouquet, C.2    Poynard, T.3    Sylla, C.4    Benalia, H.5    Fretz, C.6
  • 51
    • 0036224677 scopus 로고    scopus 로고
    • Impact of hepatitis B and C on graft loss and mortality of patients after kidney transplantation
    • Breitenfeldt MK, Rasenack J, Berthold H, Olschewski M, Schroff J, Strey C, et al. Impact of hepatitis B and C on graft loss and mortality of patients after kidney transplantation. Clin Transplant 2002;16(2):130-6.
    • (2002) Clin Transplant , vol.16 , Issue.2 , pp. 130-136
    • Breitenfeldt, M.K.1    Rasenack, J.2    Berthold, H.3    Olschewski, M.4    Schroff, J.5    Strey, C.6
  • 52
    • 4544314855 scopus 로고    scopus 로고
    • Hepatitis C infection, time in renal replacement therapy, and outcome after kidney transplantation
    • Bruchfeld A, Wilczek H, Elinder CG. Hepatitis C infection, time in renal replacement therapy, and outcome after kidney transplantation. Transplantation 2004;78(5):745-50.
    • (2004) Transplantation , vol.78 , Issue.5 , pp. 745-750
    • Bruchfeld, A.1    Wilczek, H.2    Elinder, C.G.3
  • 53
    • 3242696194 scopus 로고    scopus 로고
    • The influence of hepatitis B and hepatitis C virus infection in the recipient on late renal allograft failure
    • Morales JM, Domínguez-Gil B, Sanz-Guajardo D, Fernández J, Escuin F. The influence of hepatitis B and hepatitis C virus infection in the recipient on late renal allograft failure. Nephrol Dial Transplant 2004;19(Suppl 3):iii72-6.
    • (2004) Nephrol Dial Transplant , vol.19 , Issue.SUPPL. 3
    • Morales, J.M.1    Domínguez-Gil, B.2    Sanz-Guajardo, D.3    Fernández, J.4    Escuin, F.5
  • 57
    • 21344433042 scopus 로고    scopus 로고
    • Natural history of hepatitis C virus-related liver fibrosis after renal transplantation
    • Kamar N, Rostaing L, Selves J, Sandres-Saune K, Alric L, Durand D. Natural history of hepatitis C virus-related liver fibrosis after renal transplantation. Am J Transplant 2005;5(7):1704-12.
    • (2005) Am J Transplant , vol.5 , Issue.7 , pp. 1704-1712
    • Kamar, N.1    Rostaing, L.2    Selves, J.3    Sandres-Saune, K.4    Alric, L.5    Durand, D.6
  • 59
    • 0003669969 scopus 로고    scopus 로고
    • U.S. Renal Data System, in, Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases
    • U.S. Renal Data System, USRDS 2002 Annual Data Report: Atlas of End-Stage Renal Disease in the United States, in, Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2002.
    • (2002) USRDS 2002 Annual Data Report: Atlas of End-Stage Renal Disease in the United States
  • 60
    • 33750619231 scopus 로고    scopus 로고
    • Coagulation disorders and hemostasis in liver disease: pathophysiology and critical assesment of current management
    • Caldwell SH, Hoffman M, Lisman T, Macik BG, Northup PG, Reddy KR, et al. Coagulation disorders and hemostasis in liver disease: pathophysiology and critical assesment of current management. Hepatology 2006;44(4):1039-46.
    • (2006) Hepatology , vol.44 , Issue.4 , pp. 1039-1046
    • Caldwell, S.H.1    Hoffman, M.2    Lisman, T.3    Macik, B.G.4    Northup, P.G.5    Reddy, K.R.6
  • 61
    • 0025191232 scopus 로고
    • Use of DDAVP in inherited and acquired platelet dysfunction
    • DiMichele DM, Hathaway WE. Use of DDAVP in inherited and acquired platelet dysfunction. Am J Hematol 1990;33(1):39-45.
    • (1990) Am J Hematol , vol.33 , Issue.1 , pp. 39-45
    • DiMichele, D.M.1    Hathaway, W.E.2
  • 62
    • 4043062139 scopus 로고    scopus 로고
    • Review article: the evolving role of liver biopsy
    • Campbell MS, Reddy KR. Review article: the evolving role of liver biopsy. Aliment Pharmacol Ther 2004;20(3):249-59.
    • (2004) Aliment Pharmacol Ther , vol.20 , Issue.3 , pp. 249-259
    • Campbell, M.S.1    Reddy, K.R.2
  • 63
    • 39549115031 scopus 로고    scopus 로고
    • Acute viral hepatitis increases liver stiffness values measured by transient elastography
    • Arena U, Vizzutti F, Corti G, Ambu S, Stasi C, Bresci S, et al. Acute viral hepatitis increases liver stiffness values measured by transient elastography. Hepatology 2008;47(2):380-4.
    • (2008) Hepatology , vol.47 , Issue.2 , pp. 380-384
    • Arena, U.1    Vizzutti, F.2    Corti, G.3    Ambu, S.4    Stasi, C.5    Bresci, S.6
  • 64
    • 39549105171 scopus 로고    scopus 로고
    • Transient elastography is unreliable for detection of cirrhosis in patients with acute liver damage
    • Sagir A, Erhardt A, Schmitt M, Häussinger D. Transient elastography is unreliable for detection of cirrhosis in patients with acute liver damage. Hepatology 2008;47(2):592-5.
    • (2008) Hepatology , vol.47 , Issue.2 , pp. 592-595
    • Sagir, A.1    Erhardt, A.2    Schmitt, M.3    Häussinger, D.4
  • 65
    • 0033900359 scopus 로고    scopus 로고
    • High ALT levels predict viremia in anti-HCV-positive HD patients if a modified normal range of ALT is applied
    • Espinosa M, Martín-Malo A, Álvarez de Lara MA, Soriano S, Aljama P. High ALT levels predict viremia in anti-HCV-positive HD patients if a modified normal range of ALT is applied. Clin Nephrol 2000;54(2):151-6.
    • (2000) Clin Nephrol , vol.54 , Issue.2 , pp. 151-156
    • Espinosa, M.1    Martín-Malo, A.2    Álvarez de Lara, M.A.3    Soriano, S.4    Aljam, P.5
  • 66
    • 0028915288 scopus 로고
    • Impact of decreased serum transaminase levels on the evaluation of viral hepatitis in hemodialysis patients
    • Guh JY, Lai YH, Yang CY, Chen SC, Chuang WL, Hsu TC, et al. Impact of decreased serum transaminase levels on the evaluation of viral hepatitis in hemodialysis patients. Nephron 1995;69(4):459-65.
    • (1995) Nephron , vol.69 , Issue.4 , pp. 459-465
    • Guh, J.Y.1    Lai, Y.H.2    Yang, C.Y.3    Chen, S.C.4    Chuang, W.L.5    Hsu, T.C.6
  • 67
    • 0034749768 scopus 로고    scopus 로고
    • Decreased serum aminotransferase activity in patients with chronic renal failure: impact on the detection of viral hepatitis
    • Fabrizi F, Lunghi G, Finazzi S, Colucci P, Pagano A, Ponticelli C, et al. Decreased serum aminotransferase activity in patients with chronic renal failure: impact on the detection of viral hepatitis. Am J Kidney Dis 2001;38(5):1009-15.
    • (2001) Am J Kidney Dis , vol.38 , Issue.5 , pp. 1009-1015
    • Fabrizi, F.1    Lunghi, G.2    Finazzi, S.3    Colucci, P.4    Pagano, A.5    Ponticelli, C.6
  • 68
    • 0034761962 scopus 로고    scopus 로고
    • Prospective study on anti-hepatitis C virus-positive patients with persistently normal serum alanine transaminase with or without detectable serum hepatitis C virus RNA
    • Martinot-Peignoux M, Boyer N, Cazals-Hatem D, Pham BN, Gervais A, Le Breton V, et al. Prospective study on anti-hepatitis C virus-positive patients with persistently normal serum alanine transaminase with or without detectable serum hepatitis C virus RNA. Hepatology 2001;34(5):1000-5.
    • (2001) Hepatology , vol.34 , Issue.5 , pp. 1000-1005
    • Martinot-Peignoux, M.1    Boyer, N.2    Cazals-Hatem, D.3    Pham, B.N.4    Gervais, A.5    Le Breton, V.6
  • 71
    • 85005773666 scopus 로고    scopus 로고
    • Natural history of hepatitis C virus carriers with persistently normal aminotransferase levels
    • Persico M, Persico E, Suozzo R, Conte S, De Seta M, Coppola L, et al. Natural history of hepatitis C virus carriers with persistently normal aminotransferase levels. Gastroenterology 2000;118(4):760-4.
    • (2000) Gastroenterology , vol.118 , Issue.4 , pp. 760-764
    • Persico, M.1    Persico, E.2    Suozzo, R.3    Conte, S.4    De Seta, M.5    Coppola, L.6
  • 72
    • 33750977258 scopus 로고    scopus 로고
    • A 24-week course of high-dose interferon-alpha plus ribavirin for Taiwanese chronic hepatitis C patients with persistently normal or near-normal alanine aminotransferase levels
    • Yu ML, Dai CY, Lee LP, Hou NJ, Hsieh MY, Huang JF, et al. A 24-week course of high-dose interferon-alpha plus ribavirin for Taiwanese chronic hepatitis C patients with persistently normal or near-normal alanine aminotransferase levels. Liver Int 2006;26(10):1187-95.
    • (2006) Liver Int , vol.26 , Issue.10 , pp. 1187-1195
    • Yu, M.L.1    Dai, C.Y.2    Lee, L.P.3    Hou, N.J.4    Hsieh, M.Y.5    Huang, J.F.6
  • 73
    • 4544313879 scopus 로고    scopus 로고
    • Interferon alfa-2b [correction of alpha-2b] and ribavirin for patients with chronic hepatitis C and normal ALT
    • Jacobson IM, Ahmed F, Russo MW, Lebovics E, Dieterich DT, Esposito SP, et al. Interferon alfa-2b [correction of alpha-2b] and ribavirin for patients with chronic hepatitis C and normal ALT. Am J Gastroenterol 2004;99(9):1700-5.
    • (2004) Am J Gastroenterol , vol.99 , Issue.9 , pp. 1700-1705
    • Jacobson, I.M.1    Ahmed, F.2    Russo, M.W.3    Lebovics, E.4    Dieterich, D.T.5    Esposito, S.P.6
  • 74
    • 9644262441 scopus 로고    scopus 로고
    • Peginterferon alfa-2a (40 kilodaltons) and ribavirin in patients with chronic hepatitis C and normal aminotransferase levels
    • Zeuzem S, Diago M, Gane E, Reddy KR, Pockros P, Prati D, et al. Peginterferon alfa-2a (40 kilodaltons) and ribavirin in patients with chronic hepatitis C and normal aminotransferase levels. Gastroenterology 2004;127(6):1724-32.
    • (2004) Gastroenterology , vol.127 , Issue.6 , pp. 1724-1732
    • Zeuzem, S.1    Diago, M.2    Gane, E.3    Reddy, K.R.4    Pockros, P.5    Prati, D.6
  • 75
    • 33749183244 scopus 로고    scopus 로고
    • Management and treatment of hepatitis C viral infection: recommendations from the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program Office
    • Yee HS, Curie SL, Darling JM, Wright TL. Management and treatment of hepatitis C viral infection: recommendations from the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program Office. Am J Gastroenterol 2006;101(10):2360-78.
    • (2006) Am J Gastroenterol , vol.101 , Issue.10 , pp. 2360-2378
    • Yee, H.S.1    Curie, S.L.2    Darling, J.M.3    Wright, T.L.4
  • 76
    • 0034889844 scopus 로고    scopus 로고
    • Long-term impact of hepatitis B C virus infection on renal transplantation
    • Lee WC, Shu KH, Cheng CH, Wu MJ, Chen CH, Lian JC. Long-term impact of hepatitis B, C virus infection on renal transplantation. Am J Nephrol 2001;21 (4):300-6.
    • (2001) Am J Nephrol , vol.21 , Issue.4 , pp. 300-306
    • Lee, W.C.1    Shu, K.H.2    Cheng, C.H.3    Wu, M.J.4    Chen, C.H.5    Lian, J.C.6
  • 79
    • 37249080855 scopus 로고    scopus 로고
    • Hepatic dysfunction in kidney transplant recipients: prevalence and impact on graft and patient survival
    • Gheith OA, Saad MA, Hassan AA, A-Eldeeb S, Agroudy AE, Esaza H, et al. Hepatic dysfunction in kidney transplant recipients: prevalence and impact on graft and patient survival. Clin Exp Nephrol 2007;11(4):309-15.
    • (2007) Clin Exp Nephrol , vol.11 , Issue.4 , pp. 309-315
    • Gheith, O.A.1    Saad, M.A.2    Hassan, A.A.3    A-Eldeeb, S.4    Agroudy, A.E.5    Esaza, H.6
  • 80
    • 0032521301 scopus 로고    scopus 로고
    • Pretransplant hepatitis C virus infection: a predictor of proteinuria after renal transplantation
    • Hestin D, Guillermin F, Castin N, Le Faou A, Champigneulles J, Kessler M. Pretransplant hepatitis C virus infection: a predictor of proteinuria after renal transplantation. Transplantation 1998;65(5):741-4.
    • (1998) Transplantation , vol.65 , Issue.5 , pp. 741-744
    • Hestin, D.1    Guillermin, F.2    Castin, N.3    Le Faou, A.4    Champigneulles, J.5    Kessler, M.6
  • 81
    • 0036232458 scopus 로고    scopus 로고
    • Association of hepatitis C with posttransplant diabetes in renal transplant patients on tacrolimus
    • Bloom RD, Rao V, Weng F, Grossman RA, Cohen D, Mange KC. Association of hepatitis C with posttransplant diabetes in renal transplant patients on tacrolimus. J Am Soc Nephrol 2002;13(5):1374-80.
    • (2002) J Am Soc Nephrol , vol.13 , Issue.5 , pp. 1374-1380
    • Bloom, R.D.1    Rao, V.2    Weng, F.3    Grossman, R.A.4    Cohen, D.5    Mange, K.C.6
  • 83
    • 33644683298 scopus 로고    scopus 로고
    • Posttransplant diabetes mellitus and HCV seropositive status after renal transplantation: meta-analysis of clinical studies
    • Fabrizi F, Martin P, Dixit V, Bunnapradist S, Kanwal F, Dulai G. Posttransplant diabetes mellitus and HCV seropositive status after renal transplantation: meta-analysis of clinical studies. Am J Transplant 2005;5(10):2433-40.
    • (2005) Am J Transplant , vol.5 , Issue.10 , pp. 2433-2440
    • Fabrizi, F.1    Martin, P.2    Dixit, V.3    Bunnapradist, S.4    Kanwal, F.5    Dulai, G.6
  • 84
    • 0029047674 scopus 로고
    • De novo membranoproliferative glomerulonephritis in hepatitis C virus-infected renal allograft recipients
    • Roth D, Cirocco R, Zucker K, Ruiz P, Viciana A, Burke G, et al. De novo membranoproliferative glomerulonephritis in hepatitis C virus-infected renal allograft recipients. Transplantation 1995;59(12):1676-82.
    • (1995) Transplantation , vol.59 , Issue.12 , pp. 1676-1682
    • Roth, D.1    Cirocco, R.2    Zucker, K.3    Ruiz, P.4    Viciana, A.5    Burke, G.6
  • 85
    • 0038353188 scopus 로고    scopus 로고
    • Recurrent glomerulonephritis following renal transplantation: an update
    • Floege J. Recurrent glomerulonephritis following renal transplantation: an update. Nephrol Dial Transplant 2003;18(7):1260-5.
    • (2003) Nephrol Dial Transplant , vol.18 , Issue.7 , pp. 1260-1265
    • Floege, J.1
  • 86
    • 33750005603 scopus 로고    scopus 로고
    • Recurrent glomerulonephritis after kidney transplantation
    • Choy BY, Chan TM, Lai KN. Recurrent glomerulonephritis after kidney transplantation. Am J Transplant 2006;6(11):2535-42.
    • (2006) Am J Transplant , vol.6 , Issue.11 , pp. 2535-2542
    • Choy, B.Y.1    Chan, T.M.2    Lai, K.N.3
  • 88
    • 34547438879 scopus 로고    scopus 로고
    • Steroid minimization in liver transplant recipients: impact on hepatitis C recurrent and post-transplant diabetes
    • Humar A, Crotteau S, Cruessner A, Kandaswamy R, Gruessner R, Payne W, et al. Steroid minimization in liver transplant recipients: impact on hepatitis C recurrent and post-transplant diabetes. Clin Transplant 2007;21(4):526-31.
    • (2007) Clin Transplant , vol.21 , Issue.4 , pp. 526-531
    • Humar, A.1    Crotteau, S.2    Cruessner, A.3    Kandaswamy, R.4    Gruessner, R.5    Payne, W.6
  • 89
    • 0031804327 scopus 로고    scopus 로고
    • Reduced severity of acute rejection in hepatitis C virus positive renal allograft recipients: are milder immunosuppressive regimens advisable?
    • Pascual J, Crespo M, Mateos ML, Marcén R, Orofino L, Burgos FJ, et al. Reduced severity of acute rejection in hepatitis C virus positive renal allograft recipients: are milder immunosuppressive regimens advisable? Transplant Proc 1998;30(4):1329-30.
    • (1998) Transplant Proc , vol.30 , Issue.4 , pp. 1329-1330
    • Pascual, J.1    Crespo, M.2    Mateos, M.L.3    Marcén, R.4    Orofino, L.5    Burgos, F.J.6
  • 90
    • 33749858938 scopus 로고    scopus 로고
    • Treatment of hepatitis C virus infection (HCV) after renal transplantation: implications for HCVpositive dialysis patients awaiting a kidney transplant
    • Kamar N, Ribes D, Izopet J, Rostaing L. Treatment of hepatitis C virus infection (HCV) after renal transplantation: implications for HCVpositive dialysis patients awaiting a kidney transplant. Transplantation 2006;82(7):853-6.
    • (2006) Transplantation , vol.82 , Issue.7 , pp. 853-856
    • Kamar, N.1    Ribes, D.2    Izopet, J.3    Rostaing, L.4
  • 91
    • 0032533428 scopus 로고    scopus 로고
    • Hepatitis C virus-associated fibrosing cholestatic hepatitis after renal transplantation: response to interferon-alpha therapy
    • Toth CM, Pascual M, Chung RT, Graeme-Cook F, Dienstag JL, Bhan AK, et al. Hepatitis C virus-associated fibrosing cholestatic hepatitis after renal transplantation: response to interferon-alpha therapy. Transplantation 1998;66(9):1254-8.
    • (1998) Transplantation , vol.66 , Issue.9 , pp. 1254-1258
    • Toth, C.M.1    Pascual, M.2    Chung, R.T.3    Graeme-Cook, F.4    Dienstag, J.L.5    Bhan, A.K.6
  • 92
    • 33947274748 scopus 로고    scopus 로고
    • Analysis of safety and efficacy of pegylated-interferon alpha-2a in hepatitis C virus positive hemodialysis patients: results from a large, multicenter audit
    • Covic A, Maftei I-D, Mardare NGI, Ionita-Radu F, Totolici C, Tuta L, et al. Analysis of safety and efficacy of pegylated-interferon alpha-2a in hepatitis C virus positive hemodialysis patients: results from a large, multicenter audit. J Nephrol 2006;19(6):794-801.
    • (2006) J Nephrol , vol.19 , Issue.6 , pp. 794-801
    • Covic, A.1    Maftei, I.-D.2    Mardare, N.G.I.3    Ionita-Radu, F.4    Totolici, C.5    Tuta, L.6
  • 93
    • 77952256322 scopus 로고    scopus 로고
    • Safety and efficacy of an escalating dose regimen of pegylated interferon alpha-2b in the treatment of haemodialysis patients with chronic hepatitis C
    • Tan SS, Abu Hassan MR, Abdullah A, Ooi BP, Korompis T, Merican MI. Safety and efficacy of an escalating dose regimen of pegylated interferon alpha-2b in the treatment of haemodialysis patients with chronic hepatitis C. J Viral Hepat 2010;17(6):410-8.
    • (2010) J Viral Hepat , vol.17 , Issue.6 , pp. 410-418
    • Tan, S.S.1    Abu Hassan, M.R.2    Abdullah, A.3    Ooi, B.P.4    Korompis, T.5    Merican, M.I.6
  • 94
    • 33645034186 scopus 로고    scopus 로고
    • Efficacy and tolerability of pegylated-interferon alpha-2a in hemodialysis patients with chronic hepatitis C
    • Kokoglu OF, Ucmak H, Hosoglu S, Cetinkaya A, Kantarceken B, Buyukbese MA, et al. Efficacy and tolerability of pegylated-interferon alpha-2a in hemodialysis patients with chronic hepatitis C. J Gastroenterol Hepatol 2006;21(3):575-80.
    • (2006) J Gastroenterol Hepatol , vol.21 , Issue.3 , pp. 575-580
    • Kokoglu, O.F.1    Ucmak, H.2    Hosoglu, S.3    Cetinkaya, A.4    Kantarceken, B.5    Buyukbese, M.A.6
  • 95
    • 31544438279 scopus 로고    scopus 로고
    • Randomized trial of pegylated interferon α-2b monotherapy in haemodialysis patients with chronic hepatitis C
    • Russo MW, Ghalib R, Sigal J, Joshi V. Randomized trial of pegylated interferon α-2b monotherapy in haemodialysis patients with chronic hepatitis C. Nephrol Dial Transplant 2006;21(2):437-43.
    • (2006) Nephrol Dial Transplant , vol.21 , Issue.2 , pp. 437-443
    • Russo, M.W.1    Ghalib, R.2    Sigal, J.3    Joshi, V.4
  • 96
    • 30044432484 scopus 로고    scopus 로고
    • American Gastroenterological Association technical review on the management of hepatitis C
    • Dienstag JL, McHutchinson JG. American Gastroenterological Association technical review on the management of hepatitis C. Gastroenterology 2006;130(1):231-64.
    • (2006) Gastroenterology , vol.130 , Issue.1 , pp. 231-264
    • Dienstag, J.L.1    McHutchinson, J.G.2
  • 98
    • 0020441682 scopus 로고
    • The kidney is the main site of interferon degradation
    • Bino T, Madar Z, Gertler A, Rosenberg H. The kidney is the main site of interferon degradation. J Interferon Res 1982;2(2):301-8.
    • (1982) J Interferon Res , vol.2 , Issue.2 , pp. 301-308
    • Bino, T.1    Madar, Z.2    Gertler, A.3    Rosenberg, H.4
  • 100
    • 0032949443 scopus 로고    scopus 로고
    • The clinical pharmacology of ribavirin
    • Glue P. The clinical pharmacology of ribavirin. Semin Liver Dis 1999;19(Suppl 1):17-24.
    • (1999) Semin Liver Dis , vol.19 , Issue.SUPPL. 1 , pp. 17-24
    • Glue, P.1
  • 101
    • 0031690013 scopus 로고    scopus 로고
    • Interferon therapy for chronic hepatitis C in hemodialysis patients: increased serum levels of interferon
    • Uchihara M, Izumi N, Sakai Y, Yauchi T, Miyake S, Sakai T, et al. Interferon therapy for chronic hepatitis C in hemodialysis patients: increased serum levels of interferon. Nephron 1998;80(1):51-6.
    • (1998) Nephron , vol.80 , Issue.1 , pp. 51-56
    • Uchihara, M.1    Izumi, N.2    Sakai, Y.3    Yauchi, T.4    Miyake, S.5    Sakai, T.6
  • 102
    • 0031593545 scopus 로고    scopus 로고
    • Pharmacokinetics of alpha IFN-2b in chronic hepatitis C virus patients undergoing chronic hemodialysis or with normal renal function: clinical implications
    • Rostaing L, Chatelut E, Payen JL, Izopet J, Thalamas C, Ton-That H, et al. Pharmacokinetics of alpha IFN-2b in chronic hepatitis C virus patients undergoing chronic hemodialysis or with normal renal function: clinical implications. J Am Soc Nephrol 1998;9(12):2344-8.
    • (1998) J Am Soc Nephrol , vol.9 , Issue.12 , pp. 2344-2348
    • Rostaing, L.1    Chatelut, E.2    Payen, J.L.3    Izopet, J.4    Thalamas, C.5    Ton-That, H.6
  • 103
    • 0034324083 scopus 로고    scopus 로고
    • Pegylated interferon-alpha 2b: pharmacokinetics, pharmacodynamics, safety, and preliminary efficacy dat Hepatitis C Intervention Therapy Group
    • Glue P, Fang JW, Rouzier-Panis R, Raffanel C, Sabo R, Gupta SK, et al. Pegylated interferon-alpha 2b: pharmacokinetics, pharmacodynamics, safety, and preliminary efficacy data. Hepatitis C Intervention Therapy Group. Clin Pharmacol Ther 2000;68(5):556-67.
    • (2000) Clin Pharmacol Ther , vol.68 , Issue.5 , pp. 556-567
    • Glue, P.1    Fang, J.W.2    Rouzier-Panis, R.3    Raffanel, C.4    Sabo, R.5    Gupta, S.K.6
  • 104
    • 18544362355 scopus 로고    scopus 로고
    • Single-dose pharmacokinetics and safety of pegylated interferon alpha 2b in patients with chronic renal dysfunction
    • Gupta SK, Pittenger AL, Swan SK, Marbury TC, Tobillo E, Batra V, et al. Single-dose pharmacokinetics and safety of pegylated interferon alpha 2b in patients with chronic renal dysfunction. J Clin Pharmacol 2002;42(10):1109-15.
    • (2002) J Clin Pharmacol , vol.42 , Issue.10 , pp. 1109-1115
    • Gupta, S.K.1    Pittenger, A.L.2    Swan, S.K.3    Marbury, T.C.4    Tobillo, E.5    Batra, V.6
  • 105
    • 33845955252 scopus 로고    scopus 로고
    • Safety and tolerability of pegylated interferon with or without low dose ribavirin for treatment of hepatitis C in hemodialysis
    • Luzon BA, Muir AJ, Heneghan MA. Safety and tolerability of pegylated interferon with or without low dose ribavirin for treatment of hepatitis C in hemodialysis. Hepatology 2005;42(Suppl):703A-704A.
    • (2005) Hepatology , vol.42 , Issue.SUPPL.
    • Luzon, B.A.1    Muir, A.J.2    Heneghan, M.A.3
  • 107
    • 33645969906 scopus 로고    scopus 로고
    • Pegylated interferon and ribavirin treatment for hepatitis C in haemodialysis patients
    • Bruchfeld A, Lindahl K, Reichard O, Carlsson T, Schvarcz R. Pegylated interferon and ribavirin treatment for hepatitis C in haemodialysis patients. J Viral Herat 2006;13(5):316-21.
    • (2006) J Viral Herat , vol.13 , Issue.5 , pp. 316-321
    • Bruchfeld, A.1    Lindahl, K.2    Reichard, O.3    Carlsson, T.4    Schvarcz, R.5
  • 110
    • 45949096855 scopus 로고    scopus 로고
    • Treatment of dialysis patients with chronic hepatitis C using pegylated interferon and low-dose ribavirin
    • Carriero D, Fabrizi F, Uriel AJ, Park J, Martin P, Dieterich DT. Treatment of dialysis patients with chronic hepatitis C using pegylated interferon and low-dose ribavirin. Int J Artif Organs 2008;31(4):295-302.
    • (2008) Int J Artif Organs , vol.31 , Issue.4 , pp. 295-302
    • Carriero, D.1    Fabrizi, F.2    Uriel, A.J.3    Park, J.4    Martin, P.5    Dieterich, D.T.6
  • 111
    • 79958287999 scopus 로고    scopus 로고
    • Combined antiviral therapy of hepatitis C virus in dialysis patients: meta-analysis of clinical trials
    • doi: 10.1111/j.1365-2893.2010.01405.x. [Epub ahead of print]
    • Fabrizi F, Dixit V, Martin P, Messa P. Combined antiviral therapy of hepatitis C virus in dialysis patients: meta-analysis of clinical trials. J Viral Hepat 2010. doi: 10.1111/j.1365-2893.2010.01405.x. [Epub ahead of print]
    • (2010) J Viral Hepat
    • Fabrizi, F.1    Dixit, V.2    Martin, P.3    Messa, P.4
  • 112
    • 0035160037 scopus 로고    scopus 로고
    • Safety of interferon and ribavirin therapy in haemodialysis patients with chronic hepatitis C: results of a pilot study
    • Tan AC, Brouwer JT, Glue P, Van Leusen R, Kauffmann RH, Schalm SW, et al. Safety of interferon and ribavirin therapy in haemodialysis patients with chronic hepatitis C: results of a pilot study. Nephrol Dial Transplant 2001;16(1):193-5.
    • (2001) Nephrol Dial Transplant , vol.16 , Issue.1 , pp. 193-195
    • Tan, A.C.1    Brouwer, J.T.2    Glue, P.3    Van Leusen, R.4    Kauffmann, R.H.5    Schalm, S.W.6
  • 113
    • 1642502319 scopus 로고    scopus 로고
    • National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification
    • Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 2003;139(2):137-47.
    • (2003) Ann Intern Med , vol.139 , Issue.2 , pp. 137-147
    • Levey, A.S.1    Coresh, J.2    Balk, E.3    Kausz, A.T.4    Levin, A.5    Steffes, M.W.6
  • 115
    • 38449093231 scopus 로고    scopus 로고
    • Valoración y seguimiento de inclusión en lista de espera para trasplante renal
    • García García M, Oppenheimer F, Valencia J. Valoración y seguimiento de inclusión en lista de espera para trasplante renal. Nefrologia 2006;26(Suppl 8):60-9.
    • (2006) Nefrologia , vol.26 , Issue.SUPPL. 8 , pp. 60-69
    • García García, M.1    Oppenheimer, F.2    Valencia, J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.